DIABELOOP

DIABELOOP is an artificial intelligence company in Grenoble, France, founded in 2015. It has raised $135.3M across 3 rounds, most recently a $17.5M Extension Round in March 2024.

My passion rules my life. Not diabetes

Headquarters
Grenoble
Founded
2015
Business Model
B2B
Total Funding
$135.3M
Last Round
$17.5M Extension RoundMar 2024
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 1 investor for this company. The full record is or through the API.

About

Diabeloop develops therapeutic artificial intelligence that automates and personalizes treatment for people with Type 1 diabetes. Founded in 2015 in Grenoble by Dr. Guillaume Charpentier and Erik Huneker, the company connects continuous glucose monitors and insulin pumps through self-learning algorithms such as DBLG1 and DBLG2. More than 11,000 patients in Europe were equipped with DBLG1 as of May 2025, with the algorithm integrated in four insulin pumps. The company works with partners including CEA-Leti, CERITD, Terumo, and ViCentra.

Summary

It has raised $135.3M in total across 3 rounds, most recently a $17.5M Extension Round in Mar 2024. Investors include LBO France.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Extension RoundSeries C ExtensionMar 2024
$17.5M

Sign up to see all 3 events

Funding: Series B through Extension Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Devoted Health

Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...

Waltham, United States1001–5000Artificial Intelligence, Healthcare
Series G+Total funding$3.5BOct 2026
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Verily Life Sciences

Verily builds AI-native precision health platforms that help healthcare organizations harmonize d...

Dallas, United States1001–5000Artificial Intelligence, Healthcare
Corporate RoundTotal funding$3.0BMar 2026
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

DIABELOOP on Indexed.vc
<a href="https://indexed.vc/companies/diabeloop"><img src="https://indexed.vc/api/badge/company/diabeloop" alt="DIABELOOP on Indexed.vc" width="260" height="76" /></a>